|
123
|
351
|
6z54A |
Crystal structure of clk3 in complex with macrocycle ods2003178 |
|
126
|
351
|
6z51A |
Crystal structure of clk3 in complex with macrocycle ods2002941 |
|
120
|
351
|
6z53A |
Crystal structure of clk3 in complex with macrocycle ods2003128 |
|
111
|
333
|
6z50A |
Crystal structure of clk1 in complex with macrocycle ods2003208 |
|
132
|
358
|
6z55A |
Crystal structure of clk3 in complex with macrocycle ods2004070 |
|
120
|
354
|
6z52A |
Crystal structure of clk3 in complex with macrocycle ods2003136 |
|
126
|
357
|
6ytwA |
Clk3 bound with benzothiazole tg003 (cpd 2) |
|
114
|
333
|
6ytiA |
Clk1 bound with eth1610 (cpd 17) |
|
116
|
338
|
6ytgA |
Clk1 bound with beta-carboline kh-carb13 (cpd 3) |
|
113
|
338
|
6ythA |
Clk1 bound with gw807982x (cpd 8) |
|
120
|
355
|
6ytyA |
Clk3 a319v mutant bound with benzothiazole tg003 (cpd 2) |
|
117
|
347
|
6yu1a |
Clk3 bound with beta-carboline kh-carb13 (cpd 3) |
|
112
|
338
|
6yteC |
Clk1 bound with benzothiazole tg003 (cpd 2) |
|
111
|
338
|
6ytaA |
Clk1 bound with imidazopyridazine (cpd 1) |
|
117
|
339
|
6ytdA |
Clk1 v324a mutant bound with benzothiazole tg003 (cpd 2) |
|
66
|
278
|
6tnbA |
X-ray structure of mps1 in complex with compound 41 |
|
77
|
278
|
6tndA |
X-ray structure of mps1 in complex with compound 79 |
|
78
|
279
|
6tncA |
X-ray structure of mps1 in complex with compound 46 |
|
74
|
282
|
6tn9A |
X-ray structure of mps1 in complex with compound 16 |
|
116
|
330
|
6r6xA |
Crystal structure of di-phosphorylated human clk1 in complex with 5-(1-methyl-1h-indol-3-yl)pyrimidin-4-amine |
|
109
|
329
|
6r6eA |
Crystal structure of di-phosphorylated human clk1 in complex with 5-(6,7-dichloro-1-methyl-1h-indol-3-yl)pyrimidin-4-amine |
|
113
|
330
|
6r8jA |
Crystal structure of di-phosphorylated human clk1 in complex with 4-(1-methyl-1h-indol-3-yl)pyrimidin-2-amine |
|
21
|
151
|
1k3nA |
Nmr structure of the fha1 domain of rad53 in complex with a rad9-derived phosphothreonine (at t155) peptide |
|
24
|
158
|
1k2mA |
Solution structure of the fha2 domain of rad53 complexed with a phosphotyrosyl peptide derived from rad9 |
|
22
|
158
|
1k2nA |
Solution structure of the fha2 domain of rad53 complexed with a phosphothreonyl peptide derived from rad9 |
|
25
|
151
|
1k3jA |
Refined nmr structure of the fha1 domain of yeast rad53 |
|
21
|
158
|
1fhrA |
Solution structure of the fha2 domain of rad53 complexed with a phosphotyrosyl peptide |
|
24
|
158
|
1fhqA |
Refined solution structure of the fha2 domain of rad53 |
|
22
|
151
|
1k3qA |
Nmr structure of the fha1 domain of rad53 in complex with a rad9-derived phosphothreonine (at t192) peptide |
|
19
|
164
|
1g3gA |
Nmr structure of the fha1 domain of yeast rad53 |
|
20
|
158
|
1dmzA |
A refined nmr structure of a new phophopeptide-binding domain containing the fha2 of rad53 |
|
113
|
338
|
6q8kA |
Clk1 with bound pyridoquinazoline |
|
104
|
337
|
6q8pA |
Structure of clk1 with bound n-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine |
|
115
|
338
|
6i5iA |
Crystal structure of clk1 in complexed with furo[3,2-b]pyridine compound 12h |
|
114
|
336
|
6i5hA |
Crystal structure of clk1 in complex with furanopyrimidin vn412 |
|
108
|
338
|
6i5lA |
Crystal structure of clk1 in complexed with furo[3,2-b]pyridine compound vn316 (derivative of compound 12h) |
|
109
|
337
|
6i5kA |
Crystal structure of clk1 in complexed with furo[3,2-b]pyridine compound vn345 (derivative of compound 12h) |
|
82
|
281
|
6gvjA |
Human mps1 kinase domain with ordered activation loop |
|
110
|
335
|
6raaA |
Clk1 kinase domain with bound imidazopyridin inhibitor tp003 |
|
113
|
350
|
6rctA |
Crystal structure of clk3 in complex with t3-clk |
|
113
|
338
|
5j1vA |
Crystal structure of human clk1 in complex with pyrido[3,4-g]quinazoline derivative zw29 (compound 13) |
|
114
|
338
|
5j1wA |
Crystal structure of human clk1 in complex with pyrido[3,4-g]quinazoline derivative zw31 (compound 14) |
|
109
|
347
|
6eirA |
Dyrk1a in complex with xmd15-27-2 |
|
78
|
280
|
6n6oA |
Crystal structure of the human ttk in complex with an inhibitor |
|
74
|
279
|
5na0A |
Ttk kinase domain in complex with a peg-linked pyrimido-indolizine |
|
79
|
279
|
5n93A |
Ttk kinase domain in complex with tc-mps1-12 |
|
80
|
279
|
5n9sA |
Ttk kinase domain in complex with bay 1161909 |
|
82
|
282
|
5mrbA |
Crystal structure of human mps1 (ttk) in complex with cpd-5 |
|
72
|
279
|
5nadA |
Ttk kinase domain in complex with bay 1217389 |
|
78
|
279
|
5n84A |
Ttk kinase domain in complex with mps-bay2b |
